InsiderFlow

Jeffrey Arcara

CRVS

Jeffrey Arcara serves as officer: Chief Business Officer at Corvus Pharmaceuticals, Inc. (CRVS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$50.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$50.5K

Companies Traded

1

CRVS

Active Period

Nov 2026

1 total trades

Most Recent

Buy CRVS

Nov 13, 2026 · $50.5K

Jeffrey Arcara's Insider Trading at Corvus Pharmaceuticals, Inc. (CRVS)

Buys

1 · $50.5K

Sells

0 · $0.00

Total Shares Bought

4,500

Total Shares Sold

0

CRVS Price Chart
Loading chart...
DateTypeValue
Nov 13, 2026 Buy$50.5K